Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

NCT06962098 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

186

Enrollment

INDIV

Sponsor class

Conditions

Diabetic Kidney Disease (DKD)

Interventions

DRUG: Isuzinaxib
DRUG: Placebo

Sponsor

Aptabio Therapeutics, Inc.